Blood-purification technology for critical care and cardiac surgery.
Independent editorial and sponsored coverage are visibly separated. Sponsored company reports carry a clear commercial-relationship disclosure and remain subject to the same sourcing, byline, date and correction standards as other newsroom reports.
CytoSorbents brings an established international blood-purification business, new clinical evidence and operating improvements to its September investor-conference appearance.
Read full report →Send verifiable public material, a factual correction or a news tip to the editorial desk. Submissions are reviewed independently and do not guarantee publication.
